- Home
- YCBD vs NDRA Comparison
YCBD vs NDRA Comparison
Compare YCBD & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- NDRA
- Stock Information
- Founded
- YCBD 2015
- NDRA 2007
- Country
- YCBD United States
- NDRA United States
- Employees
- YCBD N/A
- NDRA N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- YCBD Health Care
- NDRA Health Care
- Exchange
- YCBD Nasdaq
- NDRA Nasdaq
- Market Cap
- YCBD 7.8M
- NDRA 7.3M
- IPO Year
- YCBD N/A
- NDRA 2017
- Fundamental
- Price
- YCBD $0.83
- NDRA $5.17
- Analyst Decision
- YCBD Strong Buy
- NDRA Strong Buy
- Analyst Count
- YCBD 1
- NDRA 1
- Target Price
- YCBD $2.00
- NDRA $38.00
- AVG Volume (30 Days)
- YCBD 474.9K
- NDRA 798.8K
- Earning Date
- YCBD 12-17-2025
- NDRA 11-14-2025
- Dividend Yield
- YCBD N/A
- NDRA N/A
- EPS Growth
- YCBD N/A
- NDRA N/A
- EPS
- YCBD N/A
- NDRA N/A
- Revenue
- YCBD $19,026,064.00
- NDRA N/A
- Revenue This Year
- YCBD $0.37
- NDRA N/A
- Revenue Next Year
- YCBD $4.95
- NDRA N/A
- P/E Ratio
- YCBD N/A
- NDRA N/A
- Revenue Growth
- YCBD N/A
- NDRA N/A
- 52 Week Low
- YCBD $0.59
- NDRA $2.90
- 52 Week High
- YCBD $6.54
- NDRA $11.96
- Technical
- Relative Strength Index (RSI)
- YCBD 38.49
- NDRA 45.13
- Support Level
- YCBD $0.94
- NDRA $4.79
- Resistance Level
- YCBD $1.09
- NDRA $5.37
- Average True Range (ATR)
- YCBD 0.12
- NDRA 0.49
- MACD
- YCBD -0.05
- NDRA -0.17
- Stochastic Oscillator
- YCBD 4.42
- NDRA 19.15
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.